PubRank

Daniele Fina

Author PubWeight™ 28.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease. Gastroenterology 2005 2.52
2 IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. J Immunol 2007 1.92
3 Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. Gastroenterology 2008 1.88
4 IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa. Eur J Immunol 2008 1.53
5 IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells. Eur J Immunol 2007 1.49
6 Characterization of IL-17A-producing cells in celiac disease mucosa. J Immunol 2010 1.40
7 A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells. Gastroenterology 2006 1.38
8 Autocrine regulation of IL-21 production in human T lymphocytes. J Immunol 2008 1.35
9 Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. Gastroenterology 2009 1.19
10 Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis. Gastroenterology 2006 1.17
11 Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease. Gastroenterology 2005 1.14
12 New mediators of immunity and inflammation in inflammatory bowel disease. Curr Opin Gastroenterol 2006 1.11
13 IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis. J Immunol 2007 1.08
14 Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid. Biochem Pharmacol 2007 1.06
15 Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation. Am J Pathol 2006 1.06
16 Smad7 expression in T cells prevents colitis-associated cancer. Cancer Res 2011 0.93
17 Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages. Inflamm Bowel Dis 2011 0.92
18 Lactobacillus paracasei subsp. paracasei B21060 suppresses human T-cell proliferation. Infect Immun 2007 0.87
19 Bacteria and mucosal immunity. Dig Liver Dis 2006 0.85
20 Genetic and pathogenetic insights into inflammatory bowel disease. Curr Gastroenterol Rep 2003 0.83
21 Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine. Gastroenterology 2009 0.82
22 Role of IL-21 in inflammatory bowel disease. Expert Rev Clin Immunol 2010 0.81
23 A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis. Gastroenterology 2006 0.80
24 Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase. Carcinogenesis 2008 0.80